Listen to this post

Are you considering a transaction in the healthcare industry? 

Join us for our complimentary webcast, Navigating Increased Scrutiny for Health Care Deals in 2024. Together with Moss Adams and America’s Physician Groups, we’ll address the new pressures facing health care systems, private equity investors, providers, and other stakeholders looking to complete a transaction in the health care ecosystem, as health care deals continue to face antitrust and regulatory scrutiny by the Department of Justice (DOJ), the Federal Trade Commission (FTC)—and now, the Department of Health and Human Services (HHS) and certain state agencies.

Our knowledgeable presenters will discuss:

  • Federal and state regulatory landscapes to review transactions and considerations for current and future deal activity.
  • Unintended consequences this increased transactional scrutiny and added regulatory burden might have on market dynamics, deal confidentiality, and financially stressed organizations looking for survival options.
  • Tension between reimbursement models and transaction pullbacks.


We encourage all stakeholders in the health care space contemplating mergers and acquisitions and strategic transactions to attend this webinar.

The panel discussion will be moderated by Eric Klein, partner and leader of Sheppard Mullin’s 200+ attorney national healthcare practice team. Eric will be joined by Bill Barcellona, EVP for Government Affairs with America’s Physician Groups, Chris Prichard, Partner and Health Care Industry Group Leader with Moss Adams LLP, Karl Rebay, Partner, Health Care Consulting, Strategy and Integration Leader with Moss Adams LLP, John Carroll, a former FTC lawyer and partner in the Antitrust and Competition Practice Group of Sheppard Mullin, and Jordan Grushkin, Leader of Firmwide OHCA Initiatives with Sheppard Mullin.